첫 페이지 News 본문

Eli Lilly's Q3 performance exceeded expectations but lowered its annual profit guidance due to a surge in revenue from "weight loss pills". Prior to Thursday's trading session, American pharmaceutical company Eli Lilly released its third quarter financial report. Although the company's Q3 revenue and profit exceeded expectations, it lowered its annual profit guidance.
您需要登录后才可以回帖 登录 | Sign Up

本版积分规则

多德德多w 新手上路
  • Follow

    0

  • Following

    0

  • Articles

    3